Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Cardiovascular therapeutics Market Research Reports

Titlepublishedprice

Endocarditis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... understand the market and pipeline status of the drugs around the Endocarditis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report pr......"
01-Jan-2017$2000

Restenosis-Pipeline Insights, 2017

By Delve Insight
"...... I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. D......"
01-Jan-2017$1250

Left Ventricular Hypertrophy-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... ricular Hypertrophy Report is to understand the market and pipeline status of the drugs around the Left Ventricular Hypertrophy to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing p......"
01-Jan-2017$2000

Atrial Fibrillation - Epidemiology Forecast To 2023

By Delve Insight
"...... prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Atrial Fibrillation. The report is built ......"
01-Jan-2017$2750

Chronic Heart Failure - Epidemiology Forecast To 2023

By Delve Insight
"...... ailure prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Chronic Heart Failure. The report i......"
01-Jan-2017$2750

Ischemic Cardiomyopathy-Pipeline Insights, 2017

By Delve Insight
"...... Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & E......"
01-Jan-2017$1250

Ventricular Arrhythmia-API Insights, 2017

By Delve Insight
"...... he API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'P......"
01-Jan-2017$1250

Ventricular Tachycardia-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Myocardial Infarction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... ction Report is to understand the market and pipeline status of the drugs around the Myocardial Infarction to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. T......"
01-Jan-2017$2000

Pulmonary Embolism - Epidemiology Forecast To 2023

By Delve Insight
"...... evalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Pulmonary Embolism. The report is built usin......"
01-Jan-2017$2750

Avail upto 50% Discount on below Publisher Reports.